Researchers at the University of Wisconsin-Madison School of Veterinary Medicine have developed a mosaic nanovaccine designed to target current and future variations of avian influenza.

“Avian influenza can mutate very quickly. This allows it to easily escape the immunity generated by the vaccine,” Adel M. Talaat, PhD, professor of microbiology…